Litigation Details for Genentech, Inc. v. Lupin Ltd. (D. Del. 2019)
✉ Email this page to a colleague
Genentech, Inc. v. Lupin Ltd. (D. Del. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-01-18 |
| Court | District Court, D. Delaware | Date Terminated | 2021-10-15 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 7,566,729; 7,635,707; 7,696,236; 7,767,225; 7,767,700; 7,816,383; 7,910,610; 7,988,994; 8,013,002; 8,084,475; 8,318,780; 8,383,150; 8,420,674; 8,592,462; 8,609,701; 8,648,098; 8,753,679; 8,754,109; 8,778,947 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Genentech, Inc. v. Lupin Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Genentech, Inc. v. Lupin Ltd. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-01-17 | 1 | U.S. Patent No. 7,566,729 25. U.S. Patent No. 7,566,729 (“the ‘729 patent”), entitled… U.S. Patent No. 7,767,700 29. U.S. Patent No. 7,767,700 (“the ‘700 patent”), entitled… U.S. Patent No. 8,013,002 35. U.S. Patent No. 8,013,002 (“the ‘002 patent”), entitled… U.S. Patent No. 8,383,150 41. U.S. Patent No. 8,383,150 (“the ‘150 patent”), entitled… U.S. Patent No. 8,609,701 47. U.S. Patent No. 8,609,701 (“the ‘701 patent”), entitled | External link to document | |
| 2021-10-15 | 22 | Patent/Trademark Report to Commissioner of Patents | B2; 7,696,236 B2; 7,767,700 B2; 8,420,674 B2; 7,566,729 B1; 7,635,707 B1; 8,592,462 B2; 8,609,701 B2; … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 7,767,225 B2;…2019 15 October 2021 1:19-cv-00109 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
